Results 61 to 70 of about 38,327 (259)

Modern concepts of the platelet in health and disease [PDF]

, 1962
Thesis (M.D.)--Boston ...
Estes, J. Worth
core  

Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism

Case Reports in Hematology, 2017
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug reaction in which heparin forms complexes with platelet factor 4 forming neoantigens that are recognized by autoantibodies.
Samuel Adediran, Nicole Agostino
doaj   +1 more source

Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2016
Introduction. Heparin-induced thrombocytopenia associated to hemodialysis is rare. In case when citrate dialysis and/or non-heparin anticoagulants are not available, only possible medication to use for anticoagulation during hemodialysis is ...
Kušić Jovana, Kulić Andrijana, Đurković Veselinka, Marković Rodoljub, Milačić Velja, Surić-Lambić Ljiljana, Peković Gordana   +6 more
doaj   +1 more source

Abciximab‐Associated Thrombocytopenia After Previous Tirofiban‐Related Thrombocytopenia [PDF]

, 2006
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90080/1/phco.26.3.423 ...
Dorsch, Michael P., Montague, Debbie, Patterson, Cam, Rodgers, Jo Ellen   +3 more
core   +1 more source

Autoimmune heparin‐induced thrombocytopenia [PDF]

Journal of Thrombosis and Haemostasis, 2017
Autoimmune heparin-induced thrombocytopenia (aHIT) indicates the presence in patients of anti-platelet factor 4 (PF4)-polyanion antibodies that are able to activate platelets strongly even in the absence of heparin (heparin-independent platelet activation).
A, Greinacher, K, Selleng, T E, Warkentin   +2 more
openaire   +2 more sources

Platelet Transfusion Is Associated With Increased Thrombosis and In‐Hospital Mortality Among Patients Hospitalized With Platelet Consumptive Disorders

European Journal of Haematology, EarlyView.
ABSTRACT Background Platelet transfusion is commonly used to reduce bleeding risk in platelet consumptive disorders. However, platelets may also promote thromboinflammatory pathways, and contemporary data evaluating the association between platelet transfusion, thrombosis, and mortality in this population are limited.
Manas Pustake, Shubhangi Deoker, Veeravenkata Garikiparthy, Kunal Sharma, Lakshmi Kattamuri, Abhizith Deoker, Abhinav Deol   +6 more
wiley   +1 more source

Smjernice Hrvatskog društva za hematologiju i transfuzijsku medicinu u dijagnostičko-terapijskom postupku za trombocitopeniju izazvanu heparinom (HIT) [Croatian Society for Haematology and Transfusion Medicine Guidelines on the diagnosis and management of heparin induced thrombocytopenia (HIT)] [PDF]

, 2012
Heparin induced thrombocytopenia (HIT) is a serious complication of heparin administration. In the last decade, this clinical syndrome has come into the focus of interest, primarily because of the severe thromboembolic complications that may lead to ...
Bošnjak, Bojana, Debeljak, Željko, Dodig, Javorka, Gojčeta, Koraljka, Golubić-Ćepulić, Branka, Kogler-Majerić, Višnja, Mesarić, Jasna, Peraica-Planinc, Ana, Prinčić, Meri, Rode, Bojan, Skorić, Boško, Stančić, Vladimir, Suvić-Križanić, Višnjica, Tomičić, Maja, Čuljak-Aleksić, Marlena, Šturm, Deana   +15 more
core  

Venous Thromboembolism (VTE) Risk Stratification in Otolaryngology: Socioeconomic and Subspecialty Insights

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
ABSTRACT Objective Venous thromboembolism (VTE) is a leading cause of preventable perioperative mortality in otolaryngology, highlighting the urgent need for validated risk assessments such as the Caprini score to guide prophylaxis and enhance patient safety.
Corinne A. Pittman, Hudson Liu, Lovedeep Singh, Serenity G. Budd, Sabrina Heman‐Ackah, Selena E. Briggs   +5 more
wiley   +1 more source

Hobson’s choice; platelet inhibition and thrombocytopenia [PDF]

, 2018
No ...
Curzen, N, Mamas, MA
core   +1 more source

Efficacy of Hepatic Artery Infusion Chemotherapy Combined With Regorafenib and Sintilimab Versus Regorafenib Alone in MSS/pMMR Colorectal Cancer Liver Metastases After Second‐Line Treatment Failure

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Microsatellite stable/proficient mismatch repair (MSS/pMMR) colorectal cancer liver metastases (CRCLM) have limited treatment options after failure of second‐line systemic therapies. Hepatic artery infusion chemotherapy (HAIC) combined with targeted therapy and immunotherapy may offer improved outcomes.
Ran You, Qingyu Xu, Lixing Wang, Bin Leng, Chendong Wang, Zeyu Yu, Ya Lu, Lingfeng Diao, Yi Lu, Guowen Yin   +9 more
wiley   +1 more source